These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7865627)

  • 1. Measurement of salivary insulin-like growth factor-I in acromegaly: comparison with serum insulin-like growth factor-I and growth hormone concentrations.
    Halimi S; Tepavcević D; Suchanek D; Giljević Z; Palvsić V; Korsić M
    Eur J Clin Chem Clin Biochem; 1994 Sep; 32(9):705-7. PubMed ID: 7865627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.
    Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients.
    Juul A; Main K; Blum WF; Lindholm J; Ranke MB; Skakkebaek NE
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):85-93. PubMed ID: 7519529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy.
    Ho KY; Weissberger AJ
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):75-83. PubMed ID: 8050134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
    Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
    Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU; Post KD; Powell JS; Wardlaw SL
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free insulin-like growth factor I (IGF-I) and IGF-II in human saliva.
    Costigan DC; Guyda HJ; Posner BI
    J Clin Endocrinol Metab; 1988 May; 66(5):1014-8. PubMed ID: 3360895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.
    Kim HJ; Kwon SH; Kim SW; Park DJ; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
    Horm Res; 2001; 56(3-4):117-23. PubMed ID: 11847474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide stimulates insulin-like growth factor binding protein-1 (IGFBP-1) levels in acromegaly.
    Ezzat S; Ren SG; Braunstein GD; Melmed S
    J Clin Endocrinol Metab; 1991 Aug; 73(2):441-3. PubMed ID: 1713220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of treatment success in patients with acromegaly: the value of serum insulin-like growth factor binding protein-3 and serum leptin measurements in comparison to plasma insulin-like growth factor I determination.
    Páramo C; Fluiters E; de la Fuente J; Andrade A; García-Mayor RV
    Metabolism; 2001 Sep; 50(9):1117-21. PubMed ID: 11555849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.
    Arosio M; Nissim M; Ballabio M; Orefice R; Bazzoni N; Faglia G
    Acta Endocrinol (Copenh); 1991 Aug; 125(2):150-9. PubMed ID: 1897332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1.
    Parfitt VJ; Flanagan D; Wood P; Leatherdale BA
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):647-52. PubMed ID: 10197081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
    Wass JA
    J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IGF-I and IGFBP-3 levels for the assessment of disease activity of acromegaly.
    Chen HS; Lin HD
    J Endocrinol Invest; 1999 Feb; 22(2):98-103. PubMed ID: 10195375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
    Riedel M; Günther T; von zur Mühlen A; Brabant G
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion.
    Bates AS; Evans AJ; Jones P; Clayton RN
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):417-23. PubMed ID: 7750196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly; effects on growth hormone and other markers of growth hormone secretion.
    Hunter SJ; Shaw JA; Lee KO; Wood PJ; Atkinson AB; Bevan JS
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):245-51. PubMed ID: 10396369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-relations between growth hormone, insulin, insulin-like growth factor-I (IGF-I), IGF-binding protein-1 (IGFBP-1) and sex hormone-binding globulin in acromegaly.
    Holly JM; Cotterill AM; Jemmott RC; Shears D; al-Othman S; Chard T; Wass JA
    Clin Endocrinol (Oxf); 1991 Apr; 34(4):275-80. PubMed ID: 1715247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new competitive enzyme immunoassay.
    Kratzsch J; Blum WF; Schenker E; Keller E; Jahreis G; Haustein B; Ventz M; Rotzsch W
    Exp Clin Endocrinol; 1993; 101(3):144-9. PubMed ID: 8223982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.